GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression ...

If you support maintaining the U.S. approach to fighting HIV/AIDS, you should welcome the DOGE review to ensure that programs ...

A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Demonstrators gathered Thursday on the steps of the Department of Health and Human Services (HHS) building for a “die-in” ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that ...

The Alabama Department of Public Health (ADPH) has announced the renewal of its STD/HIV At-Home Specimen Collection ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

The Federal Ministry of Health and Social Welfare, through the National AIDS, Viral Hepatitis and STIs Control Programme ...